P. Mantuano

发表

β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation

E. Conte, O. Cappellari, A. De Luca, 2021, Biomolecules.

Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.

B. Nico, R. Tamma, A. De Luca, 2016, Pharmacological research.

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients

E. Bertini, E. Mercuri, A. Yuryev, 2021, Frontiers in Physiology.

Ergogenic Effect of BCAAs and L-Alanine Supplementation: Proof-of-Concept Study in a Murine Model of Physiological Exercise

E. Conte, O. Cappellari, A. De Luca, 2020, Nutrients.

A long‐term treatment with taurine prevents cardiac dysfunction in mdx mice

E. Conte, A. De Luca, S. Pierno, 2019, Translational research : the journal of laboratory and clinical medicine.

Effect of exercise on telomere length and telomere proteins expression in mdx mice

S. Messina, A. De Luca, G. Vita, 2020, Molecular and Cellular Biochemistry.

“The Social Network” and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies

O. Cappellari, A. De Luca, P. Mantuano, 2020, Cells.

Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies.

E. Conte, O. Cappellari, A. De Luca, 2019, Pharmacological research.

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.

R. Grange, E. Conte, A. De Luca, 2017, Journal of applied physiology.

Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders

A. De Luca, N. Denora, V. Laquintana, 2019, International journal of molecular sciences.

Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy.

O. Cappellari, A. De Luca, R. Capogrosso, 2021, PloS one.

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy

E. Conte, A. De Luca, A. Liantonio, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics.

Annemieke Aartsma-Rus, A. De Luca, M. van Putten, 2022, Journal of neuromuscular diseases.

Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine

A. Modesti, A. De Luca, T. Fiaschi, 2018, Data in brief.

Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.

E. Conte, A. De Luca, A. Liantonio, 2014, American journal of physiology. Cell physiology.

Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications

E. Conte, A. De Luca, A. Liantonio, 2023, International journal of molecular sciences.

Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.

A. Modesti, A. De Luca, T. Fiaschi, 2018, Journal of proteomics.

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

A. Paradiso, A. Azzariti, L. Porcelli, 2013, Molecular oncology.

Effect of a long‐term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy

E. Conte, A. De Luca, R. Capogrosso, 2018, Biochemical pharmacology.

Alteration of STIM1/Orai1-Mediated SOCE in Skeletal Muscle: Impact in Genetic Muscle Diseases and Beyond

E. Conte, A. De Luca, A. Liantonio, 2021, Cells.

Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors.

A. Paradiso, A. Azzariti, L. Porcelli, 2012, Current pharmaceutical design.

BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading.

E. Conte, O. Cappellari, A. De Luca, 2021, Pharmacological research.

Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia

E. Conte, O. Cappellari, A. De Luca, 2023, Nutrients.

Synthetic lethality to overcome cancer drug resistance.

H Calvert, A. Paradiso, A. Azzariti, 2012, Current medicinal chemistry.

LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model

E. Conte, O. Cappellari, A. De Luca, 2023, Disease models & mechanisms.

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy

G. Cruciani, A. Torsello, E. Conte, 2023, Frontiers in Immunology.

Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future.

B. Boccanegra, P. Mantuano, Gianluca Trifirò, 2024, CNS drugs.

Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions

E. Conte, O. Cappellari, A. Liantonio, 2024, Frontiers in pharmacology.